Cardiac Hypertrophy and the WNT/Frizzled Pathway

Hypertension - United States
doi 10.1161/01.hyp.0000255947.79237.61
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

AKAP-Lbc Mobilizes a Cardiac Hypertrophy Signaling Pathway

Molecular Cell
Cell BiologyMolecular Biology
2008English

Long Non‐coding RNA Cardiac Hypertrophy‐associated Regulator Governs Cardiac Hypertrophy via Regulating miR‐20b and the Downstream PTEN/AKT Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

PM2.5 Induced Cardiac Hypertrophy via CREB/GSK3b/SOS1 Pathway and Metabolomics Alterations

Oncotarget
Oncology
2018English

cGMP and Cardiac Hypertrophy

BMC pharmacology & toxicology
MedicinePharmacology
2015English

Simvastatin Prevents Isoproterenol-Induced Cardiac Hypertrophy Through Modulation of the JAK/STAT Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

1,25-Vitamin D3 Promotes Cardiac Differentiation Through Modulation of the WNT Signaling Pathway

Endocrine Abstracts
2015English

Protection Against Cardiac Hypertrophy by Geniposide Involves the GLP-1 Receptor / AMPKα Signalling Pathway

British Journal of Pharmacology
Pharmacology
2016English

Crocetin Protects Against Cardiac Hypertrophy by Blocking MEK-ERK1/2 Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2010English

Cardiac .BETA.-Adrenergic Signaling Pathway Alteration in Isoproterenol-Induced Cardiac Hypertrophy in Male Sprague-Dawley Rats.

Japanese Heart Journal
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy